IT8223147A0 - Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva. - Google Patents

Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva.

Info

Publication number
IT8223147A0
IT8223147A0 IT8223147A IT2314782A IT8223147A0 IT 8223147 A0 IT8223147 A0 IT 8223147A0 IT 8223147 A IT8223147 A IT 8223147A IT 2314782 A IT2314782 A IT 2314782A IT 8223147 A0 IT8223147 A0 IT 8223147A0
Authority
IT
Italy
Prior art keywords
protractive
transfer
active substance
pharmaceutical preparation
hydrodynamically balanced
Prior art date
Application number
IT8223147A
Other languages
English (en)
Other versions
IT1158048B (it
Inventor
Prabhakar Ranchhorda Sheth
Jacques Levon Tossounian
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IT8223147A0 publication Critical patent/IT8223147A0/it
Application granted granted Critical
Publication of IT1158048B publication Critical patent/IT1158048B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT23147/82A 1981-09-14 1982-09-07 Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva IT1158048B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30149881A 1981-09-14 1981-09-14

Publications (2)

Publication Number Publication Date
IT8223147A0 true IT8223147A0 (it) 1982-09-07
IT1158048B IT1158048B (it) 1987-02-18

Family

ID=23163649

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23147/82A IT1158048B (it) 1981-09-14 1982-09-07 Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva

Country Status (11)

Country Link
JP (1) JPS5857315A (it)
AT (1) AT385199B (it)
BE (1) BE894376A (it)
BG (1) BG60526B2 (it)
CH (1) CH652025A5 (it)
DE (1) DE3232873A1 (it)
FR (1) FR2512676B1 (it)
GB (1) GB2105590B (it)
IT (1) IT1158048B (it)
MX (1) MX9203173A (it)
NL (1) NL190746C (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
EP0198769A3 (en) * 1985-04-12 1987-09-02 Forest Laboratories, Inc. Floating sustained release therapeutic compositions
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
DE3642668A1 (de) * 1986-12-13 1988-06-23 Kamprad Joachim Schmerzmittel fuer menschen
EP0324947B2 (de) * 1987-12-31 1997-08-20 ASTA Medica Aktiengesellschaft Synergistische Kombination von Decarboxylasehemmern und L-Dopa-Pellets
ATE119766T1 (de) * 1989-10-26 1995-04-15 Nippon Shinyaku Co Ltd Zubereitung für den magen.
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
NZ274901A (en) * 1993-10-29 1997-03-24 Reckitt & Colmann Prod Ltd Chewable gelatin capsule for the treatment of gastric reflux or peptic ulceration comprising polymeric material, carbonate or bicarbonate salt and oil or hydrophilic based liquid vehicle
WO1995011667A1 (en) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
US5840756A (en) * 1995-07-21 1998-11-24 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition of L-DOPA ester
EP1560569A4 (en) * 2002-10-11 2006-03-22 Depomed Dev Ltd GASTRORETENTIVE LEVODOPA DELIVERY FORM
DE102004039196B4 (de) 2004-08-12 2008-07-31 Dr.Kamprad Kg Neue Formulierung für L-Tryptophan
DE102010023828A1 (de) * 2010-06-15 2011-12-15 IIP - Institut für industrielle Pharmazie, Forschungs- und Entwicklungsgesellschaft mbH Pharmazeutisches Präparat, welches Entacapon, Levodopa und Carbidopa enthält
DE102014003744A1 (de) 2014-03-10 2015-09-10 Laboratorium für Lebensmittelwissenschaft (FPE) - Eidgenössische Technische Hochschule Zürich (ETH) Produkt zur oralen Verabreichung bei Menschen oder Tieren mit mikrostrukturierten, gekapselten Inhaltsstoffen sowie Vorrichtung zum Herstellen eines derartigen Produkts und Verfahren zum Herstellen dieses Produkts
DE102022103658A1 (de) 2022-02-16 2023-08-17 Joachim Kamprad Arzneimittelzusammensetzung enthaltend L-Tryptophan (L-Try) und L-5-Hydroxytryptophan (5-HTP) sowie einen peripheren Abbauhemmer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409996A (de) * 1961-06-16 1966-03-31 Hoffmann La Roche Verfahren zur Herstellung von substituierten Hydrazinen
US3557292A (en) * 1968-08-16 1971-01-19 Hoffmann La Roche Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
ZA713877B (en) * 1970-07-24 1972-03-29 Hoffmann La Roche Pharmaceutical composition
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
CA1018456A (en) * 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations

Also Published As

Publication number Publication date
CH652025A5 (de) 1985-10-31
DE3232873A1 (de) 1983-03-31
GB2105590A (en) 1983-03-30
FR2512676B1 (fr) 1987-01-23
JPH0341447B2 (it) 1991-06-24
AT385199B (de) 1988-02-25
GB2105590B (en) 1985-05-30
MX9203173A (es) 1992-07-01
FR2512676A1 (fr) 1983-03-18
NL190746B (nl) 1994-03-01
JPS5857315A (ja) 1983-04-05
BG60526B2 (bg) 1995-07-28
BE894376A (fr) 1983-03-14
ATA341582A (de) 1987-08-15
NL190746C (nl) 1994-08-01
IT1158048B (it) 1987-02-18
NL8203343A (nl) 1983-04-05

Similar Documents

Publication Publication Date Title
IT8223147A0 (it) Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva.
NO159166C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NO862956D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO821904L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO863228D0 (no) Fremgangsmaate for fremstilling av farmakodynamiske aktive benzimidazol-derivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
IT8621294A0 (it) Procedimento di preparazione di monosialoganglioside.
NO865012D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
ES517428A0 (es) Procedimiento de preparacion de derivados bencilidenicos.
IT1157058B (it) Procedimento per la preparazione di acril e metaacrilamidi n.sostituite
NO811134L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-derivater.
NL193821B (nl) Farmaceutisch preparaat.
NO813577L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperdin-derivater.
IT8220717A0 (it) Preparato farmaceutico vasodilatatore.
IT8224818A0 (it) Procedimento per la preparazione del7-metil-3-metilen-7-otten-1-il-propionato.

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 155

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 155, 19920424; F. HOFFMANN-LA ROCHE AG.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960919